Javascript must be enabled to continue!
Transdermal Iontophoresis of Insulin
View through CrossRef
The delivery of large peptides through the skin poses a significant challenge, and various strategies are under active investigation for enhancing the transdermal permeation. For large peptides, it is difficult to achieve significant permeation using iontophoresis alone. Hence a combination of fatty acids with iontophoresis was hypothesized to result in higher enhancement than achieved with either of them alone. Saturated fatty acids and <i>cis</i> unsaturated fatty acids were studied in combination with iontophoresis using excised rat skin. The skin was pretreated for 2 h with an ethanolic (EtOH) solution of 5% w/v or v/v fatty acids, namely lauric acid (LA), oleic acid (OA), linoleic acid (LOA) and linolenic acid (LLA), followed by either passive or iontophoretic permeation (0.5 mA/cm<sup>2</sup> for 6 h). Fourier transform infrared spectroscopy (FT-IR) was used to investigate the biophysical changes on treatment with fatty acid/EtOH or neat fatty acid, mainly focusing on the infrared region at 2,920, 1,710 and 1,720 cm<sup>–1</sup>. Unsaturated fatty acids showed higher enhancement than LA, and the enhancement increased with the number of double bonds. On the other hand, in the presence of iontophoresis, LA/EtOH showed the highest enhancement. Neat LOA did not show any significant difference (p > 0.05) compared to the LOA/EtOH combination. FT-IR studies revealed that fatty acids act by interacting with the skin lipids. All the fatty acids showed synergistic enhancement when combined with iontophoresis. The flux enhancement was highest with LA, which in the presence of iontophoresis showed 20 times enhancement of insulin flux in comparison to passive flux and 9 times enhancement as compared to iontophoresis alone. Flux enhancement of unsaturated fatty acids was in the following decreasing order LOA > OA > LLA.
Title: Transdermal Iontophoresis of Insulin
Description:
The delivery of large peptides through the skin poses a significant challenge, and various strategies are under active investigation for enhancing the transdermal permeation.
For large peptides, it is difficult to achieve significant permeation using iontophoresis alone.
Hence a combination of fatty acids with iontophoresis was hypothesized to result in higher enhancement than achieved with either of them alone.
Saturated fatty acids and <i>cis</i> unsaturated fatty acids were studied in combination with iontophoresis using excised rat skin.
The skin was pretreated for 2 h with an ethanolic (EtOH) solution of 5% w/v or v/v fatty acids, namely lauric acid (LA), oleic acid (OA), linoleic acid (LOA) and linolenic acid (LLA), followed by either passive or iontophoretic permeation (0.
5 mA/cm<sup>2</sup> for 6 h).
Fourier transform infrared spectroscopy (FT-IR) was used to investigate the biophysical changes on treatment with fatty acid/EtOH or neat fatty acid, mainly focusing on the infrared region at 2,920, 1,710 and 1,720 cm<sup>–1</sup>.
Unsaturated fatty acids showed higher enhancement than LA, and the enhancement increased with the number of double bonds.
On the other hand, in the presence of iontophoresis, LA/EtOH showed the highest enhancement.
Neat LOA did not show any significant difference (p > 0.
05) compared to the LOA/EtOH combination.
FT-IR studies revealed that fatty acids act by interacting with the skin lipids.
All the fatty acids showed synergistic enhancement when combined with iontophoresis.
The flux enhancement was highest with LA, which in the presence of iontophoresis showed 20 times enhancement of insulin flux in comparison to passive flux and 9 times enhancement as compared to iontophoresis alone.
Flux enhancement of unsaturated fatty acids was in the following decreasing order LOA > OA > LLA.
Related Results
A Review on Iontophoresis: A Noble Drug Delivery Tool for Management of Plantar Fasciopathy Using Ayurveda Drugs
A Review on Iontophoresis: A Noble Drug Delivery Tool for Management of Plantar Fasciopathy Using Ayurveda Drugs
Iontophoresis is an innovative transdermal drug delivery technique that uses electrical currents to enhance the permeation of drugs through the skin. This method holds significant ...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Enhanced Transdermal Delivery of Bisoprolol Hemifumarate via Combined Effect of Iontophoresis and Chemical Enhancers: Ex Vivo Permeation/In Vivo Pharmacokinetic Studies
Enhanced Transdermal Delivery of Bisoprolol Hemifumarate via Combined Effect of Iontophoresis and Chemical Enhancers: Ex Vivo Permeation/In Vivo Pharmacokinetic Studies
Bisoprolol hemifumarate (BH) is an antihypertensive drug that is used as first-line treatment for chronic hypertension and angina pectoris. Our study was performed to enhance the t...
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
Abstract
Abstract 4908
Insulin resistance can be a major problem in patients with diabetes mellitus. Although multiple reasons can result in this prob...
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
The aim of this study is to evaluate the cost-effectiveness of continuous subcutaneous insulin infusion (CSII) to multiple daily insulin injection (MDI) either with analogues or w...
WILLINGNESS-TO-PAY FOR INSULIN IN DIABETES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
WILLINGNESS-TO-PAY FOR INSULIN IN DIABETES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
Background: Insulin treatment is necessary for all patients with type 1 diabetes and a subset of patients with type 2 diabetes. However, lifetime insulin treatment is relatively co...
KELCH-3 (KLHL3): A Potential Regulator of Insulin-Induced Renal
Haemodynamic Alterations in Obesity
KELCH-3 (KLHL3): A Potential Regulator of Insulin-Induced Renal
Haemodynamic Alterations in Obesity
Background: The contribution of elevated insulin levels to renal
disease in pre-diabetic obesity remains underappreciated, as glomerular
...
940-P: Porous Insulin Microneedles for Diabetes Treatment
940-P: Porous Insulin Microneedles for Diabetes Treatment
Introduction and Objective: Patients with type 1 and type 2 diabetes are subjected to insulin injection therapies. Repeated subcutaneous insulin administrations leads to physiologi...

